DRAVET SYNDROME (DS)
Clinical trials for DRAVET SYNDROME (DS) explained in plain language.
Never miss a new study
Get alerted when new DRAVET SYNDROME (DS) trials appear
Sign up with your email to follow new studies for DRAVET SYNDROME (DS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study tests safer switch from homemade CBD to approved seizure drug in kids
Disease control Not yet recruitingThis study aims to find the best way to switch children with Dravet or Lennox-Gastaut syndrome from artisanal (non-pharmaceutical) cannabidiol to the FDA-approved drug Epidiolex. About 25 children aged 2 to 18 will gradually replace their artisanal CBD with Epidiolex over two wee…
Matched conditions: DRAVET SYNDROME (DS)
Phase: PHASE4 • Sponsor: Elizabeth Donner • Aim: Disease control
Last updated May 17, 2026 09:04 UTC
-
Wearable brain sensors could Fine-Tune seizure drug dosing
Knowledge-focused Not yet recruitingThis study looks at whether wearing small, portable devices at home to track brain activity and vital signs can help doctors feel more confident when adjusting the dose of fenfluramine for people with Dravet syndrome or Lennox-Gastaut syndrome. About 20 patients aged 3 and older …
Matched conditions: DRAVET SYNDROME (DS)
Phase: NA • Sponsor: Byteflies • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC